The Patent Finder

Terms ending in 2037

Bold Limited

Every in-force patent on Bold Limited's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,633,380Use of TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] for the Treatment of Cancer
In force
 · Low confidence
Bold Therapeutics, Inc.In forceLow confidence
1 of 1 patent shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited